- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05202756
Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide - Randomized Trial
August 29, 2025 updated by: Butler Hospital
Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide
The primary aim of the present study is leverage existing infrastructure to develop novel technological features for a novel personalized smartphone intervention system, called the Mobile Application to Prevent Suicide (MAPS), and to establish feasibility, acceptability, safety, and estimate key parameters for primary outcomes (i.e., suicidal ideation and behavior; re-hospitalization), and target mechanisms.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02912
- Brown University
-
Providence, Rhode Island, United States, 02906
- Butler Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Presence of suicidal ideation and/or suicidal behavior in the past month
- Between the ages of 18 and 70
- Able to read, write, and understand English well enough to complete study procedures
- Owns a smartphone
Exclusion Criteria:
- Current psychotic or manic symptoms severe enough to interfere with completion of study procedures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mobile Application to Prevent Suicide (MAPS)
Participants receiving MAPS will receive the Safety Planning Intervention (SPI) which will be uploaded into the smartphone app.
They will be prompted four times per day to complete a brief ecological momentary assessment "check-in" inquiring about their cognitions, affect, and behavior, including suicidal thoughts and behaviors.
Based on these responses, they will be provided with coping strategies from their safety plans and from a database of coping strategies created by study staff.
They will also have access to emergency phone numbers, the coping strategies database, and can communicate with their study clinician through a text-like interface in the app.
They will receive this intervention for one month.
|
Safety Planning Intervention, ecological momentary intervention smartphone app system, and bidirectional communication with study clinician.
|
|
Active Comparator: EMA Monitoring Only (EMO)
Participants in this condition will receive the Safety Planning Intervention (SPI) and will receive ecological momentary assessment prompts on the same schedule as the MAPS condition.
However, they will not have access to any other MAPS features.
|
Safety Planning Intervention; ecological momentary assessment only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of Research (Recruitment)
Time Frame: Baseline
|
Measured by recruitment rate.
|
Baseline
|
|
Patient Satisfaction
Time Frame: 1 month
|
Measured using the Client Satisfaction Questionnaire, a self-report measure of satisfaction with treatment.
Scores range from 8 to 32, with higher scores representing higher satisfaction.
|
1 month
|
|
Acceptability of MAPS Intervention
Time Frame: 1 month
|
Feedback on qualitative interview.
|
1 month
|
|
Satisfaction with MAPS Intervention
Time Frame: 4 weeks
|
Measured by protocol completion rate.
|
4 weeks
|
|
Suicidal Ideation and Behavior
Time Frame: 6 months
|
Will be assessed using the Columbia Suicide Severity Rating Scale, items from the Modified Scale for Suicidal Ideation, and ecological momentary assessment of suicidal ideation and behavior.
The Columbia Suicide Severity Rating Scale can provide presence/absence of suicidal ideation and suicidal behavior, as well as a suicidal ideation score ranging from 0 to 5 with higher scores representing more severe ideation, and a suicidal ideation intensity rating from 0-25 with higher scores representing more intense ideation.
|
6 months
|
|
Acceptability of Research Procedures
Time Frame: 1 month
|
Feedback on qualitative interview.
|
1 month
|
|
Acceptability of Research (Dropout)
Time Frame: 6 months
|
Measured by dropout rate.
|
6 months
|
|
Ecological Momentary Assessment (EMA) Adherence
Time Frame: 4 weeks
|
Number of assessments completed out of total
|
4 weeks
|
|
Rehospitalization
Time Frame: 6 months
|
Number of inpatient rehospitalizations will be assessed using the Treatment History Interview and medical records review.
|
6 months
|
|
Emergency Department Visits
Time Frame: 6 months
|
Number of emergency department visits will be assessed using the Treatment History Interview and medical records review.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Use of MAPS Intervention-delivered Coping Strategies (target mechanism)
Time Frame: 4 weeks
|
Coping strategy use will be measured in three ways: (1) when participants are prompted to use a coping strategy via MAPS, followup prompts ask whether or not they used the coping skill, (2) in each EMA survey, participants are asked whether or not they used any coping skills since the last survey, and (3) the system provides output with regard to how many times participants dial a support contact phone number through the MAPS app.
|
4 weeks
|
|
Reduction of Negative Affect (target mechanism)
Time Frame: 4 weeks
|
Negative affect will be measured using Positive and Negative Affect Scale (PANAS-X) items on ecological momentary assessment surveys.
Each emotion item on the PANAS-X is rated on a 1-5 scale based on how participants feel, with 1 indicating "very slightly or not at all" and 5 indicating "extremely."
|
4 weeks
|
|
Self-Efficacy (target mechanism)
Time Frame: 4 weeks
|
Coping self-efficacy will be measured using the Coping Self-Efficacy Scale.
Self-efficacy for seeking mental health care will be measured by the Self-Efficacy to Seek Mental Health Care Scale.
The total score can range from 0-260; the higher the score, the higher the level of coping self-efficacy.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 14, 2024
Primary Completion (Actual)
April 30, 2025
Study Completion (Actual)
April 30, 2025
Study Registration Dates
First Submitted
January 3, 2022
First Submitted That Met QC Criteria
January 19, 2022
First Posted (Actual)
January 21, 2022
Study Record Updates
Last Update Posted (Estimated)
September 5, 2025
Last Update Submitted That Met QC Criteria
August 29, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1678556
- R34MH124971 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
After all data have been collected and the results of the studies published, de-identified data will be made available to other qualified researchers on request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicidal Ideation
-
Northwestern UniversityNot yet recruitingSuicidal Ideation and Behavior
-
University GhentRecruitingSuicide | Suicidal Ideation and Behavior | Crisis InterventionBelgium
-
Shira BarzilaySchneider Children's Medical Center, IsraelRecruiting
-
University of WashingtonUnited States Department of Defense; Military Suicide Research ConsortiumCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation ActiveUnited States
-
The Catholic University of AmericaUniversity of Washington; VA Office of Research and DevelopmentCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation Active
-
Emory UniversityGeorgia Institute of TechnologyCompletedSuicide, Suicidal IdeationUnited States
-
Henry M. Jackson Foundation for the Advancement...University of Pennsylvania; University of Michigan; Duke University; US Department... and other collaboratorsUnknownSuicide, Attempted | Suicidal Ideation ActiveUnited States
-
Columbia UniversityNational Institute of Mental Health (NIMH)RecruitingSuicidal Ideation and BehaviorUnited States
-
Bradley HospitalNational Institute of Mental Health (NIMH); Instituto Nacional de Psiquiatría...Not yet recruitingSuicidal Ideation/BehaviorMexico
-
Oriana Arellano FaúndezActive, not recruitingSuicidal Ideation | Suicidal Ideation and BehaviorsChile
Clinical Trials on Mobile Application to Prevent Suicide (MAPS)
-
Butler HospitalNational Institute of Mental Health (NIMH); Brown UniversityCompletedSuicidal Ideation | Suicide, Attempted | Suicide | Suicide and Self-harmUnited States
-
Butler HospitalAmerican Foundation for Suicide Prevention (AFSP)CompletedSuicidal Ideation | Suicide, Attempted | Suicide | Suicide and Self-harmUnited States
-
Butler HospitalAmerican Foundation for Suicide Prevention (AFSP)RecruitingSuicidal Ideation | Suicide, Attempted | Suicide | Suicide and Self-harmUnited States
-
University of UtahNational Institute of Mental Health (NIMH)Completed
-
Division of General Surgery , Mt. Sinai HospitalCompletedInflammatory Bowel Diseases | Colorectal Cancer | Surgery | Utilization, Health Care | Post Discharge MonitoringCanada
-
University of RochesterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedSuicide, Attempted | Drug Use | Alcohol; Use, ProblemUnited States
-
University Hospital, Clermont-FerrandRecruitingBipolar Disorder Type I or II (According to DSM-5)France
-
Oslo University HospitalNorwegian Association for Children with Congenital Heart Disease (FFHB)CompletedStress, Psychological | Congenital Heart Disease in ChildrenNorway
-
University of California, San FranciscoCompletedType 1 Diabetes
-
Burcu Dişli OktarCompletedContraception UseTurkey (Türkiye)